Uno Health, a service aimed at increasing access to benefits and savings for lower-income Americans, has launched the Uno Savings Guide. This free tool helps individuals of all ages, including Medicare and Medicaid recipients, by determining eligibility for financial benefit…
FlexIt, a leader in virtual fitness and wellness, is excited to announce the launch of FlexTogether™, a groundbreaking platform designed to connect individuals globally through innovative wellness experiences. This new initiative features FlexIt’s proprietary AI Class Creator™ Technology, which enhances…
Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is excited to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this key role, Jacques will spearhead the development and execution…
LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its multivalent toxoid vaccine candidate, LBT-SA7. The vaccine is designed…
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™, at two centers in Australia. The trial aims to evaluate…
Axoft, a neurotechnology company, has announced the approval of its first-in-human clinical study, set to begin in early 2025 at The Panama Clinic. The study will explore the usability of Axoft’s innovative soft materials, which mimic the mechanical properties of…
SV Health Investors, a prominent healthcare-focused private equity firm, is excited to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. In this role, A.J. will continue to lead investments, oversee the SV portfolio, and contribute to…
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, has announced a new partnership with precision oncology company Guardant Health Inc. (Nasdaq: GH). This collaboration will provide biopharmaceutical researchers with access to COTA’s research-grade electronic health record…
Palleon Pharmaceuticals, a leader in glyco-immunology drug development for autoimmune diseases and cancer, has announced a collaboration and licensing agreement with Shanghai Henlius Biotech, Inc. (2696.HK). The agreement focuses on the development and commercialization of Palleon’s novel human sialidase enzyme…
Insitro, a machine learning-driven drug discovery and development company, announced today that it has received $25 million from Bristol Myers Squibb (NYSE: BMY) following the achievement of discovery milestones and the selection of the first novel genetic target for amyotrophic…
